European Neuropsychopharmacology
Volume 20, Issue 4 , Pages 226-235 , April 2010

Memory in humans is unaffected by central H1-antagonism, while objectively and subjectively measured sedation is increased

  • P. Van Ruitenbeek

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Neuropsychology and Psychopharmacology Faculty of Psychology and Neuroscience, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands. Tel.: +31 43 3881026; fax: +31 43 3884560.
    • ,
  • A. Vermeeren

      Affiliations

    • Tel.: +31 43 388 1952; fax: +31 43 388 4560.
    • ,
  • W.J. Riedel

      Affiliations

    • Tel.: +31 43 388 4322; fax: +31 43 388 4560.

Received 28 July 2009 ,Revised 10 December 2009 ,Accepted 12 December 2009.

References 

  1. Acevedo SF, Ohtsu H, Benice TS, Rizk-Jackson A, Raber J. Age-dependent measures of anxiety and cognition in male histidine decarboxylase knockout (Hdc(−/−)) mice. Brain Res. 2006;1071:113–123
  2. Alvarez EO, Ruarte MB. Glutamic acid and histamine-sensitive neurons in the ventral hippocampus and the basolateral amygdala of the rat: functional interaction on memory and learning processes. Behav. Brain Res. 2004;152:209–219
  3. Bacciottini L, Passani MB, Mannaioni PF, Blandina P. Interactions between histaminergic and cholinergic systems in learning and memory. Behav. Brain Res. 2001;124:183–194
  4. Berchou R, Chayasirisobhon S, Green V, Mason K. The pharmacodynamic properties of lorazepam and methylphenidate drugs on event-related potentials and power spectral analysis in normal subjects. Clin. Electroencephalogr. 1986;17:176–180
  5. Blandina P, Efoudebe M, Cenni G, Mannaioni P, Passani MB. Acetylcholine, histamine, and cognition: two sides of the same coin. Learn Mem. 2004;11:1–8
  6. Bond A, Lader M. The use of analogue scales in rating subjective feelings. Br. J. Med. Psychol. 1974;47:211–218
  7. Bond A, Lader M. Differential effects of oxazepam and lorazepam on aggressive responding. Psychopharmacology (Berl). 1988;95:369–373
  8. Borbely AA. A two process model of sleep regulation. Hum. Neurobiol. 1982;1:195–204
  9. Braver TS, Cohen JD, Nystrom LE, Jonides J, Smith EE, Noll DC. A parametric study of prefrontal cortex involvement in human working memory. Neuroimage. 1997;5:49–62
  10. Busto UE, Kaplan HL, Wright CE, Gomez-Mancilla B, Zawertailo L, Greenblatt DJ, et al. A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam. J. Clin. Psychopharmacol. 2000;20:628–635
  11. Curran HV. Psychopharmacological perspectives on memory. In:  Tulving E,  Craik FIM editor. The Oxford Handbook of Memory. Oxford: Oxford University Press; 2000;
  12. Curran HV, Pooviboonsuk P, Dalton JA, Lader MH. Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine. Psychopharmacology (Berl). 1998;135:27–36
  13. Dai H, Kaneko K, Kato H, Fujii S, Jing Y, Xu A, et al. Selective cognitive dysfunction in mice lacking histamine H1 and H2 receptors. Neurosci. Res. 2007;57:306–313
  14. De Brabander A, Deberdt W. Effect of hydroxyzine on attention and memory. Hum. Psychopharmacol. 1990;5:357–362
  15. Dunlap WP, Cortina JM, Vaslow JB, Burke MJ. Meta-analysis of experiments with matched groups or repeated measures designs. Psychological Methods. 1996;1:170–177
  16. Ebert U, Oertel R, Kirch W. Physostigmine reversal of midazolam-induced electroencephalographic changes in healthy subjects. Clin. Pharmacol. Ther. 2000;67:538–548
  17. File SE, Lister RG. Do lorazeam-induced deficits in learning result from impaired rehearsal, reduced motivation or increased sedation?. Br. J. Clin. Pharmacol. 1982;14:545–550
  18. Friedman D, Johnson R. Event-related potential (ERP) studies of memory encoding and retrieval: a selective review. Microsc. Res. Tech. 2000;51:6–28
  19. Galliaud E, Taillard J, Sagaspe P, Valtat C, Bioulac B, Philip P. Sharp and sleepy: evidence for dissociation between sleep pressure and nocturnal performance. J. Sleep Res. 2008;17:11–15
  20. Garbarg M, Arrang JM, Rouleau A, Ligneau X, Tuong MD, Schwartz JC, et al. S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist. J. Pharmacol. Exp. Ther. 1992;263:304–310
  21. Gevins A, Smith ME, McEvoy LK. Tracking the cognitive pharmacodynamics of psychoactive substances with combinations of behavioral and neurophysiological measures. Neuropsychopharmacology. 2002;26:27–39
  22. Gomez CM, Vaquero E, Lopez-Mendoza D, Gonzalez-Rosa J, Vazquez-Marrufo M. Reduction of EEG power during expectancy periods in humans. Acta Neurobiol. Exp. (Wars). 2004;64:143–151
  23. Greenblatt DJ. Clinical pharmacokinetics of oxazepam and lorazepam. Clin. Pharmacokinet. 1981;6:89–105
  24. Greenblatt DJ, von Moltke LL, Harmatz JS, Durol AL, Daily JP, Graf JA, et al. Differential impairment of triazolam and zolpidem clearance by ritonavir. J. Acquir. Immune. Defic. Syndr. 2000;24:129–136
  25. Griffiths MJ, Preece AW, Green JL. Monitoring sedation levels by EEG spectral analysis. Anesth. Prog. 1991;38:227–231
  26. Hanks GW, O'Neill WM, Simpson P, Wesnes K. The cognitive and psychomotor effects of opioid analgesics. II. A randomized controlled trial of single doses of morphine, lorazepam and placebo in healthy subjects. Eur. J. Clin. Pharmacol. 1995;48:455–460
  27. Hindmarch , Shamsi Z. The effects of single and repeated administration of ebastine on cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers. Curr. Med. Res. Opin. 2001;17:273–281
  28. Jasper HH. The ten-twenty electrode system of the international federation. Electroencephalogr. Clin. Neurophysiol. 1957;10:371–375
  29. Klapdor K, Hasenohrl RU, Huston JP. Facilitation of learning in adult and aged rats following bilateral lesions of the tuberomammillary nucleus region. Behav. Brain Res. 1994;61:113–116
  30. Mintzer MZ, Griffiths RR. Lorazepam and scopolamine: a single-dose comparison of effects on human memory and attentional processes. Exp. Clin. Psychopharmacol. 2003;11:56–72
  31. Mintzer MZ, Griffiths RR. Drugs, memory, and metamemory: a dose-effect study with lorazepam and scopolamine. Exp. Clin. Psychopharmacol. 2005;13:336–347
  32. Miyazaki S, Imaizumi M, Onodera K. Ameliorating effects of histidine on scopolamine-induced learning deficits using an elevated plus-maze test in mice. Life Sci. 1995;56:1563–1570
  33. Otten LJ, Donchin E. Relationship between P300 amplitude and subsequent recall for distinctive events: dependence on type of distinctiveness attribute. Psychophysiology. 2000;37:644–661
  34. Palacios JM, Wamsley JK, Kuhar MJ. The distribution of histamine H1-receptors in the rat brain: an autoradiographic study. Neuroscience. 1981;6:15–37
  35. Parsons ME, Ganellin CR. Histamine and its receptors. Br. J. Pharmacol. 2006;147(Suppl 1):S127–S135
  36. Passani MB, Bacciottini L, Mannaioni PF, Blandina P. Central histaminergic system and cognition. Neurosci. Biobehav. Rev. 2000;24:107–113
  37. Passani MB, Lin JS, Hancock A, Crochet S, Blandina P. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders. Trends Pharmacol. Sci. 2004;25:618–625
  38. Patat A, Gram LF, Dubruc C, Brohier S, Cabanis MJ, Rosenzweig P. Effects of mizolastine, a new antihistamine, on psychomotor performance and memory in elderly subjects. Int. Clin. Psychopharmacol. 1994;9:101–108
  39. Polich J. Updating P300: an integrative theory of P3a and P3b. Clin. Neurophysiol. 2007;118:2128–2148
  40. Preston GC, Broks P, Traub M, Ward C, Poppleton P, Stahl SM. Effects of lorazepam on memory, attention and sedation in man. Psychopharmacology (Berl). 1988;95:208–215
  41. Ramaekers JG, Uiterwijk MM, O'Hanlon JF. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur. J. Clin. Pharmacol. 1992;42:363–369
  42. Rammsayer TH, Rodewald S, Groh D. Dopamine-antagonistic, anticholinergic, and GABAergic effects on declarative and procedural memory functions. Brain Res. Cogn. Brain Res. 2000;9:61–71
  43. Rey, A., 1964. L'exam psychologique dans les cas d'encéphalopathie traumatique. Presses Universitaires de France.
  44. Riedel WJ, Klaassen T, Deutz NE, van Someren A, van Praag HM. Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology (Berl). 1999;141:362–369
  45. Riedel WJ, Van Praag H. Avoiding and managing anticholinergic effects of antidepressants. CNS Drugs. 1995;3:245–259
  46. Saletu B, Grunberger J, Sieghart W. Pharmaco-EEG, behavioural methods and blood levels in the comparison of temazepam and flunitrazepam. Acta Psychiatr. Scand. Suppl. 1986;332:67–94
  47. Sannita WG, Crimi E, Riela S, Rosadini G, Brusasco V. Cutaneous antihistaminic action of cetirizine and dose-related EEG concomitants of sedation in man. Eur. J. Pharmacol. 1996;300:33–41
  48. Schreckenberger M, Lange-Asschenfeldt C, Lochmann M, Mann K, Siessmeier T, Buchholz HG, et al. The thalamus as the generator and modulator of EEG alpha rhythm: a combined PET/EEG study with lorazepam challenge in humans. Neuroimage. 2004;22:637–644
  49. Semlitsch HV, Anderer P, Schuster P, Presslich O. A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. Psychophysiology. 1986;23:695–703
  50. Simons FE, Reggin JD, Roberts JR, Simons KJ. Benefit/risk ratio of the antihistamines (H1-receptor antagonists) terfenadine and chlorpheniramine in children. J. Pediatr. 1994;124:979–983
  51. Tashiro M, Mochizuki H, Iwabuchi K, Sakurada Y, Itoh M, Watanabe T, et al. Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain. Life Sci. 2002;72:409–414
  52. Theunissen EL, Jonkman LM, Kuypers KP, Ramaekers JG. A combined neurophysiological and behavioural study into the stimulating effects of fexofenadine on performance. J. Psychopharmacol. 2006;20:496–505
  53. Theunissen EL, Vermeeren A, van Oers AC, van Maris I, Ramaekers JG. A dose-ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo. Clin. Exp. Allergy. 2004;34:250–258
  54. Turner C, Handford AD, Nicholson AN. Sedation and memory: studies with a histamine H-1 receptor antagonist. J. Psychopharmacol. 2006;20:506–517
  55. Van Ruitenbeek P, Vermeeren A, Riedel WJ. Histamine H1-receptor blockade in humans affects psychomotor performance but not memory. J. Psychopharmacol. 2008;22:663–672
  56. Veltman DJ, Rombouts SA, Dolan RJ. Maintenance versus manipulation in verbal working memory revisited: an fMRI study. Neuroimage. 2003;18:247–256
  57. Vermeeren A, Jackson JL, Muntjewerff ND, Quint PJ, Harrison EM, O'Hanlon JF. Comparison of acute alprazolam (0.25, 0.50 and 1.0 mg) effects versus those of lorazepam 2 mg and placebo on memory in healthy volunteers using laboratory and telephone tests. Psychopharmacology (Berl). 1995;118:1–9
  58. Verster JC, Volkerts ER, van Oosterwijck AW, Aarab M, Bijtjes SI, De Weert AM, et al. Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood. J. Allergy Clin. Immunol. 2003;111:623–627
  59. Volkerts ER, Van Willigenburg AP, Van Laar MW, Maes RA. Does cetirizine belong to the new generation of antihistamines? An investigation into its acute and subchronic effects on highway driving, psychometric test performance and daytime sleepiness. Hum. Psychopharm. Clin. Exp. 1992;7:227–238
  60. Vuurman EF, Uiterwijk MM, Rosenzweig P, O'Hanlon JF. Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers. Eur. J. Clin. Pharmacol. 1994;47:253–259
  61. Vuurman EF, Rikken GH, Muntjewerff ND, de Halleux F, Ramaekers JG. Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements. Eur. J. Clin. Pharmacol. 2004;60:307–313
  62. Watter S, Geffen GM, Geffen LB. The n-back as a dual-task: P300 morphology under divided attention. Psychophysiology. 2001;38:998–1003
  63. Wiech NL, Martin JS. Absence of an effect of terfenadine on guinea pig brain histamine H1-receptors in vivo determined by receptor binding techniques. Arzneimittelforschung. 1982;32:1167–1170
  64. Wijtmans M, Leurs R, de Esch I. Histamine H3 receptor ligands break ground in a remarkable plethora of therapeutic areas. Expert Opin. Investig. Drugs. 2007;16:967–985
  65. World-Medical-Association, 1964. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects.
  66. Yanai K, Watanabe T, Yokoyama H, Meguro K, Hatazawa J, Itoh M, et al. Histamine H1 receptors in human brain visualized in vivo by [11C]doxepin and positron emission tomography. Neurosci. Lett. 1992;137:145–148
  67. Zarrindast MR, Parsaei L, Ahmadi S. Repeated administration of histamine improves memory retrieval of inhibitory avoidance by lithium in mice. Pharmacology. 2008;81:187–194

PII: S0924-977X(09)00280-6

doi: 10.1016/j.euroneuro.2009.12.003

European Neuropsychopharmacology
Volume 20, Issue 4 , Pages 226-235 , April 2010

Article Tools

* Image Usage & Resolution